122 related articles for article (PubMed ID: 27891063)
1. Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness.
Erbayraktar Z; Alural B; Erbayraktar RS; Erkan EP
Cancer Cell Int; 2016; 16():88. PubMed ID: 27891063
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
3. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.
Montagnoli A; Valsasina B; Croci V; Menichincheri M; Rainoldi S; Marchesi V; Tibolla M; Tenca P; Brotherton D; Albanese C; Patton V; Alzani R; Ciavolella A; Sola F; Molinari A; Volpi D; Avanzi N; Fiorentini F; Cattoni M; Healy S; Ballinari D; Pesenti E; Isacchi A; Moll J; Bensimon A; Vanotti E; Santocanale C
Nat Chem Biol; 2008 Jun; 4(6):357-65. PubMed ID: 18469809
[TBL] [Abstract][Full Text] [Related]
4. Cell division cycle 7 is a potential therapeutic target in oral squamous cell carcinoma and is regulated by E2F1.
Jin S; Ma H; Yang W; Ju H; Wang L; Zhang Z
J Mol Med (Berl); 2018 Jun; 96(6):513-525. PubMed ID: 29713760
[TBL] [Abstract][Full Text] [Related]
5. DNA Replication Dynamics and Cellular Responses to ATP Competitive CDC7 Kinase Inhibitors.
Rainey MD; Quachthithu H; Gaboriau D; Santocanale C
ACS Chem Biol; 2017 Jul; 12(7):1893-1902. PubMed ID: 28560864
[TBL] [Abstract][Full Text] [Related]
6. CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.
Li Q; Xie W; Wang N; Li C; Wang M
Transl Oncol; 2018 Apr; 11(2):300-306. PubMed ID: 29413763
[TBL] [Abstract][Full Text] [Related]
7. Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil.
Li W; Zhao XL; Shang SQ; Shen HQ; Chen X
Curr Cancer Drug Targets; 2015; 15(3):196-204. PubMed ID: 25643258
[TBL] [Abstract][Full Text] [Related]
8. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
Montagnoli A; Moll J; Colotta F
Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
[TBL] [Abstract][Full Text] [Related]
9. The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds.
Sasi NK; Tiwari K; Soon FF; Bonte D; Wang T; Melcher K; Xu HE; Weinreich M
PLoS One; 2014; 9(11):e113300. PubMed ID: 25412417
[TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
[TBL] [Abstract][Full Text] [Related]
11. Cdc7 kinase - a new target for drug development.
Swords R; Mahalingam D; O'Dwyer M; Santocanale C; Kelly K; Carew J; Giles F
Eur J Cancer; 2010 Jan; 46(1):33-40. PubMed ID: 19815406
[TBL] [Abstract][Full Text] [Related]
12. Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer.
Li J; Hu H; He J; Hu Y; Liu M; Cao B; Chen D; Ye X; Zhang J; Zhang Z; Long W; Lian H; Chen D; Chen L; Yang L; Zhang Z
Transl Oncol; 2024 Jan; 39():101825. PubMed ID: 37992591
[TBL] [Abstract][Full Text] [Related]
13. Genetic interactions between CDC7 and CDC28: growth inhibition of cdc28-1N by Cdc7 point mutants.
Ohtoshi A; Arai K; Masai H
Genes Cells; 1996 Oct; 1(10):895-904. PubMed ID: 9077449
[TBL] [Abstract][Full Text] [Related]
14. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
Peng G; Liao Y; Shen C
Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
[TBL] [Abstract][Full Text] [Related]
15. MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.
Song Y; Wang P; Zhao W; Yao Y; Liu X; Ma J; Xue Y; Liu Y
Exp Cell Res; 2014 May; 324(1):54-64. PubMed ID: 24657544
[TBL] [Abstract][Full Text] [Related]
16. Cdc7-Dbf4-mediated phosphorylation of HSP90-S164 stabilizes HSP90-HCLK2-MRN complex to enhance ATR/ATM signaling that overcomes replication stress in cancer.
Cheng AN; Fan CC; Lo YK; Kuo CL; Wang HC; Lien IH; Lin SY; Chen CH; Jiang SS; Chang IS; Juan HF; Lyu PC; Lee AY
Sci Rep; 2017 Dec; 7(1):17024. PubMed ID: 29209046
[TBL] [Abstract][Full Text] [Related]
17. Nuclear PGK1 Alleviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication.
Li X; Qian X; Jiang H; Xia Y; Zheng Y; Li J; Huang BJ; Fang J; Qian CN; Jiang T; Zeng YX; Lu Z
Mol Cell; 2018 Nov; 72(4):650-660.e8. PubMed ID: 30392930
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models.
Natoni A; Coyne MR; Jacobsen A; Rainey MD; O'Brien G; Healy S; Montagnoli A; Moll J; O'Dwyer M; Santocanale C
Cancers (Basel); 2013 Jul; 5(3):901-18. PubMed ID: 24202326
[TBL] [Abstract][Full Text] [Related]
19. Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells.
Montagnoli A; Tenca P; Sola F; Carpani D; Brotherton D; Albanese C; Santocanale C
Cancer Res; 2004 Oct; 64(19):7110-6. PubMed ID: 15466207
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones.
Kurasawa O; Oguro Y; Miyazaki T; Homma M; Mori K; Iwai K; Hara H; Skene R; Hoffman I; Ohashi A; Yoshida S; Ishikawa T; Cho N
Bioorg Med Chem; 2017 Apr; 25(7):2133-2147. PubMed ID: 28284870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
